July 2024 | AIChE

You are here

July 2024

Eno Ebong

Directs the “Ebong Mechanobiology Laboratory”, where research currently focuses on studying how the mechanical forces of blood flow and tissue stiffness affect endothelial cells, which line the blood vessels and guard them from dysfunction that leads to diseases like atherosclerosis, cancer metastasis, and neurodegeneration. Much of the research focus is on studying the structure and function of the protective gel-like layer of sugar molecules and proteins coating the surface of the endothelial cells—called the glycocalyx—to understand, on a molecular level, how mechanobiology remodels the...Read more

Kolade Adebowale

Dr. Adebowale received his Ph.D. from Stanford University in 2021 under the guidance of Professor Ovijit Chaudhuri, and his postdoctoral training at Harvard University with Professor Samir Mitragotri. While at Stanford, Dr. Adebowale received the NSF GRFP, a Stanford Graduate Fellowship, and an NIH F31 grant, and was in the Stanford Sarafan ChEM-H Chemistry-Biology Interface Training Program. At Harvard, Dr. Adebowale was awarded an NSF Ascend – MPS postdoctoral fellowship and was an NIH MOSAIC K99/R00 scholar. Dr. Adebowale’s main research areas are biomaterials, mechanobiology, and...Read more

Juana Mendenhall

Dr. Juana Mendenhall is currently the Walter E. Massey Professor of Physical Sciences at Morehouse College, President and Founder of TheraViscTM, LLC, a company thatspecializes in developing viscosupplementinjectable gels to help with knee injuries, and the TEDx licensee for TEDx Morehouse College. Her ground-breaking medical technology isone of the first medical technologies to show real potential in healing osteoarthritis. As a result, Dr. Mendenhall recently filed a patent on her innovative hydrogels. Her work has been featured on Atlanta CBS 46 and at the Platform conference designed...Read more

Shaniel Bowen

Shaniel Bowen is a School of Engineering Distinguished Postdoctoral Fellow at the Massachusetts Institute of Technology as part of its Postdoctoral Fellowship Program for Engineering Excellence. Her research concerns the pathogenesis, diagnosis, and treatment of pelvic floor disorders and, more broadly, improving women’s health and health equity.

 

Shaniel received her B.S. and M.S. in Biomedical Engineering at the University of Connecticut as an NSF Bridge to the Doctorate Fellow and her Ph.D. Bioengineering at the University of Pittsburgh as a NASEM Ford...Read more

Ted W. Love

Dr. Love has a long and distinguished career in the biopharmaceutical industry. He most recently served as president and CEO of Global Blood Therapeutics (GBT), a biotech company founded in 2011 to address sickle cell disease. Dr. Love led GBT’s growth from a pre-clinical start-up into a multi-national commercial business and introduced the first innovative rationally designed, disease-modifying treatment for sickle cell disease. GBT

was acquired by Pfizer for $5.8 billion in October 2022.

In addition to his ongoing commitment to the sickle cell disease community, Dr....Read more

Pages